Skip to content

    Recently Viewed

      Listening...

      what-you-need-to-know-about-johnson-and-johnsons-2023-first-quarter-earnings-0423.jpg

      What you need to know about Johnson & Johnson’s 2023 first-quarter earnings

      Check out this infographic breakdown of the company’s first-quarter 2023 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.

      Share Article
      share to
      Inset - Quarterly Earnings Ribbon

      This morning, Johnson & Johnson shared its first-quarter performance.

      Since its founding in 1886, the company has grown to become the world’s largest, most diversified healthcare products company, with more than 150,000 employees across the globe working every day to help change the trajectory of health for humanity.

      “Johnson & Johnson reported another quarter of strong results across our business in the first quarter of 2023,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “We remain focused on the successful separation of our Consumer Health business and are confident in the long-term growth prospects of our Pharmaceutical and MedTech businesses that continue to drive meaningful value for Johnson & Johnson shareholders.”

      For more details about the company’s 2023 first-quarter results, and to read a message from Chairman of the Board and Chief Executive Officer Joaquin Duato, here’s an infographic that highlights key stats.


      NEWQ12023EarningsIG

      Johnson & Johnson’s 2023 Earnings

      Read the earnings press release, which includes full financial details for the first quarter of 2023.

      Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.

      More from Johnson & Johnson

      Innovation
      Two cardiac electrophysiologists performing a cardiac ablation procedure to treat AFib

      What is cardiac ablation?

      For American Heart Month, learn how Johnson & Johnson is innovating to help treat the millions of people who are living with atrial fibrillation and other conditions that cause an irregular heartbeat.
      Latest news
       Biomedical scientist Robert Langer headshot

      Biomedical scientist Robert Langer receives the 2023 Dr. Paul Janssen Award for Biomedical Research

      Each year, Johnson & Johnson honors a scientist currently working in academia, industry or a scientific institute who has made a significant contribution toward the improvement of public health.
      Health & wellness
       Blue latex gloved hand pointing at a brain MRI scan to pinpoint brain circuits associated with depression symptoms

      Is this the end of one-size-fits-all treatments for depression?

      Johnson & Johnson is working to bring personalized psychiatry to the 7 in 10 people with depression whose treatments aren’t getting the job done.
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.